Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655070 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium
A Early Phase 1 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT00655070 is a Early Phase 1 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 9 participants.
The verdict
NCT00655070, a Early Phase 1 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether the use application of low frequency ultrasound, administered by the Timi3 ultrasound device, increases myocardial blood flow to the heart, in subjects with reduced myocardial blood flow at rest (hibernating myocardium). The primary endpoint of the trial is to assess the increase in myocardial blood flow from baseline to post Timi3 Ultrasound treatment in a hypoperfused region of myocardium. Positron emission tomography (PET) imaging will be used to noninvasively evaluate cardiac blood flow. The hypothesis is that ultrasound increases blood flow in hibernating myocardium.
Interventions
- DEVICE Timi3 Transthoracic ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655070
The ClinicalTrials.gov registry entry for NCT00655070 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Timi3 Transthoracic ultrasound is the first listed.
NCT00655070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655070 about?
NCT00655070 is a clinical study titled "Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium". The purpose of this study is to evaluate whether the use application of low frequency ultrasound, administered by the Timi3 ultrasound device, increases myocardial blood flow to the heart, in subjects with reduced myocardial blood flow at rest (hibernating myocardium). The primary endpoint of the tr...
What is the current status of trial NCT00655070?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2008-04. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00655070?
The interventions under investigation include: Timi3 Transthoracic ultrasound (DEVICE).
Who is sponsoring clinical trial NCT00655070?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.